About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 971096, 6 pages
http://dx.doi.org/10.1155/2013/971096
Clinical Study

Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma

1Department of Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, No. 197 Ruijin er Road, Shanghai 200025, China
2Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, No. 197 Ruijin er Road, Shanghai 200025, China

Received 29 April 2013; Revised 20 July 2013; Accepted 16 August 2013

Academic Editor: Izumi Takeyoshi

Copyright © 2013 Ying Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ying Liu, Zhengbao Ye, Wenqi Xi, et al., “Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma,” BioMed Research International, vol. 2013, Article ID 971096, 6 pages, 2013. doi:10.1155/2013/971096